Nuvation Bio (NUVB) Retained Earnings (2020 - 2026)

Nuvation Bio (NUVB) has reported Retained Earnings for 7 consecutive years, with -$1.1 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Retained Earnings fell 203769.72% year-over-year to -$1.1 billion; the TTM figure through Mar 2026 stood at -$1.1 billion (down 203769.72% YoY), while the FY2025 annual figure was -$1.1 billion, down 194754.45% from the prior year.
• Retained Earnings was little changed at -$1.1 billion in Q1 2026 per NUVB's latest filing, from -$1.1 billion in the prior quarter.
• Across five years, Retained Earnings topped out at $1.4 million in Q3 2024 and bottomed at -$1.1 billion in Q4 2025.
• Historically, Retained Earnings has averaged -$256.7 million across 5 years, with a median of -$4.4 million in 2023.
• Annual changes were most pronounced in 2024 — Retained Earnings soared 216.57% — and 2026, when it slumped 203769.72%.
• Nuvation Bio's Retained Earnings stood at -$5.5 million in 2022, then surged by 103.28% to $181000.0 in 2023, then jumped by 216.57% to $573000.0 in 2024, then sank by 194754.45% to -$1.1 billion in 2025, then advanced by 0.48% to -$1.1 billion in 2026.
• Business Quant data shows NUVB's Retained Earnings at -$1.1 billion in Q1 2026, -$1.1 billion in Q4 2025, and -$1.1 billion in Q3 2025.